Clearside Biomedical Shares Outstanding 2015-2021 | CLSD

Clearside Biomedical shares outstanding from 2015 to 2021. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Clearside Biomedical Annual Shares Outstanding
(Millions of Shares)
2020 47
2019 38
2018 31
2017 25
2016 13
2015 2
2014 2
Clearside Biomedical Quarterly Shares Outstanding
(Millions of Shares)
2021-06-30 58
2021-03-31 57
2020-12-31 47
2020-09-30 47
2020-06-30 45
2020-03-31 45
2019-12-31 38
2019-09-30 38
2019-06-30 38
2019-03-31 34
2018-12-31 31
2018-09-30 32
2018-06-30 32
2018-03-31 27
2017-12-31 25
2017-09-30 25
2017-06-30 25
2017-03-31 25
2016-12-31 13
2016-09-30 20
2016-06-30 8
2016-03-31 3
2015-12-31 2
2015-09-30 3
2015-06-30 2
2015-03-31 2
2014-12-31
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.340B $0.008B
Clearside Biomedical, Inc. is a biopharmaceutical company is engaged in developing first-in-class drug therapies to treat blinding diseases of the eye using Clearside proprietary suprachoroidal space(TM) microinjector. Its products include CLS-1001 for the treatment of macular edema associated with non-infectious uveitis; CLS-1003 for the treatment of macular edema associated with retinal vein occlusion; and CLS-1002 program for the treatment of wet age-related macular degeneration. Clearside Biomedical, Inc. is headquartered in Alpharetta, Georgia.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $127.994B 8.52
Bio-Rad Laboratories (BIO.B) United States $21.730B 46.31
QIAGEN (QGEN) Netherlands $12.309B 20.85
Biohaven Pharmaceutical Holding (BHVN) United States $9.150B 0.00
Emergent Biosolutions (EBS) United States $2.677B 6.46
Arcus Biosciences (RCUS) United States $2.522B 0.00
Myovant Sciences (MYOV) United Kingdom $1.905B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.799B 0.00
Zymeworks (ZYME) Canada $1.071B 0.00
Ambrx Biopharma (AMAM) United States $0.474B 0.00
SQZ Biotechnologies (SQZ) United States $0.341B 0.00
Enzo Biochem (ENZ) United States $0.160B 15.76